Publication | Open Access
Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study
70
Citations
25
References
2017
Year
Combining DCE-MRI and ctDNA predicts duration of anti-angiogenic response to regorafenib and may improve patient management with potential health/economic implications.
| Year | Citations | |
|---|---|---|
Page 1
Page 1